Skip to content
E2 · Observational studyCohortPEM unclearCross-sectionalPeer-reviewed
Standard · 3 min

Do people with ME/CFS and joint hypermobility represent a disease subgroup? An analysis using registry data.

Mudie, Kathleen, Ramiller, Allison, Whittaker, Sadie et al.

Frontiers in neurology2024DOIPubMed

Design
Cross-sectional
Participants
Not reported
PEM required
Unclear
Case definition
Not stated in the abstract

Quick Summary

This study looked at whether ME/CFS patients with loose, flexible joints (joint hypermobility) form a distinct group with different symptoms and health impacts. Researchers surveyed 815 ME/CFS patients and found that about 16% had joint hypermobility. These patients reported worse quality of life, more pain, and more symptoms affecting their nervous system, thinking, digestion, and muscles compared to ME/CFS patients without joint hypermobility.

Why It Matters

ME/CFS is highly heterogeneous, and identifying clinical subgroups could enable better diagnosis and targeted treatment strategies. This study provides evidence that ME/CFS patients with joint hypermobility—particularly those with concurrent EDS—may represent a distinct subgroup requiring specialized assessment and management approaches, potentially improving clinical outcomes.

Observed Findings

What the study reports it measured.

  • 15.5% of ME/CFS registry participants met criteria for joint hypermobility based on self-reported Beighton scores.
  • JH+ participants were more frequently female and reported higher rates of EDS, POTS, and family history of EDS.
  • JH+ participants reported significantly worse health-related quality of life, particularly in physical functioning and pain domains.
  • JH+ participants experienced higher burden of autonomic, neurocognitive, headache, gut, and musculoskeletal symptoms.
  • Sensitivity analysis suggested ME/CFS with concurrent JH+ and EDS was associated with more severe symptoms and greater functional impairment.

Inferred Conclusions

What the authors interpret from those results.

  • ME/CFS patients with joint hypermobility represent a clinically distinct subgroup with more severe symptomatology and reduced quality of life.
  • The overlap between ME/CFS, joint hypermobility, and EDS suggests these conditions may share common pathophysiological mechanisms worth investigating.
  • Comprehensive clinical assessment for joint hypermobility and connective tissue disorders should be integrated into ME/CFS evaluation protocols.

Remaining Questions

  • What are the underlying biological mechanisms linking joint hypermobility, ME/CFS, and autonomic/neurocognitive dysfunction?
  • Does validated clinical assessment of hypermobility (rather than self-reported Beighton scores) confirm these associations and their clinical significance?
  • Are specific therapeutic interventions more effective for ME/CFS patients with versus without joint hypermobility?
  • What proportion of ME/CFS with JH+ also meet formal diagnostic criteria for hEDS or other connective tissue disorders?

What This Study Does Not Prove

This study does not establish that joint hypermobility causes ME/CFS or is responsible for worse outcomes—it only shows an association. Self-assessed Beighton scores lack clinical validation and may not accurately reflect true hypermobility status. The cross-sectional design cannot determine temporal relationships or whether the associations reflect shared underlying biological mechanisms.

Explore further

About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →

Cite this study

The first block is for the primary paper and is the citation you should use in research work. The atlas-snapshot line only applies if you are specifically referring to this atlas’s reading of the paper on the date shown.

Primary citation

Mudie, Kathleen, Ramiller, Allison, Whittaker, Sadie, & Phillips, Leslie E (2024). Do people with ME/CFS and joint hypermobility represent a disease subgroup? An analysis using registry data.. Frontiers in neurology. https://doi.org/10.3389/fneur.2024.1324879

BibTeX

@article{mecfsatlas-mudie-2024-people-cfs,
  author  = {Mudie, Kathleen and Ramiller, Allison and Whittaker, Sadie and Phillips, Leslie E},
  title   = {Do people with ME/CFS and joint hypermobility represent a disease subgroup? An analysis using registry data.},
  journal = {Frontiers in neurology},
  year    = {2024},
  doi     = {10.3389/fneur.2024.1324879},
  note    = {PubMed: 38545281},
  url     = {https://www.mecfsatlas.com/evidence/mudie-2024-people-cfs},
}

Atlas snapshot reference

ME/CFS Atlas. Generator v1 / Scanner v1.4 / policy v0.1. Accessed 2026-11-14. https://www.mecfsatlas.com/evidence/mudie-2024-people-cfs

Contribute

Private, reviewed by a human. Not a public comment thread.